These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer? Lygidakis NJ; Papadopoulou P Hepatogastroenterology; 1995; 42(5):587-96. PubMed ID: 8751219 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital. Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197 [TBL] [Abstract][Full Text] [Related]
6. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744 [TBL] [Abstract][Full Text] [Related]
7. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection]. Ridwelski K; Meyer F; Schmidt U; Lippert H Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961 [TBL] [Abstract][Full Text] [Related]
9. Unresectable pancreatic cancer: is a multi-modality approach a promising therapeutical alternative? Lygidakis NJ; Dedemati G; Spenzaris N; Theodoropoulou M Hepatogastroenterology; 1997; 44(16):1222-8. PubMed ID: 9261631 [TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the head of the pancreas. Onoue S; Katoh T; Chigira H; Shibata Y; Matsuo K; Suzuki M Hepatogastroenterology; 2002; 49(44):549-52. PubMed ID: 11995493 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of cell mediated immunity in advanced pancreatic carcinoma before and after treatment with interleukin-2 (IL-2). Abdel-Wahab M; El-Shennawy F; Agha S; Ragab E; Fathi O; Sultan A; Elghawalby N; Ezzat F Hepatogastroenterology; 1999 May; 46 Suppl 1():1293-6. PubMed ID: 10429977 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy for pancreatic cancer: an evolving paradigm. Zhu AX; Clark JW; Willett CG Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience. Chao C; Hoffman JP; Ross EA; Torosian MH; Eisenberg BL Am Surg; 2000 Apr; 66(4):378-85; discussion 386. PubMed ID: 10776876 [TBL] [Abstract][Full Text] [Related]
14. Results of immunochemo-surgery for gastric carcinoma. Kim JP; Yu HJ; Lee JH Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936 [TBL] [Abstract][Full Text] [Related]
15. D1 versus D2 pancreatoduodenectomy in surgical therapy of pancreatic head cancer. Gazzaniga GM; Cappato S; Papadia F; Mori L; Filauro M Hepatogastroenterology; 2001; 48(41):1471-8. PubMed ID: 11677990 [TBL] [Abstract][Full Text] [Related]
16. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer. Kosuge T; Kiuchi T; Mukai K; Kakizoe T; Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736 [TBL] [Abstract][Full Text] [Related]
17. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537 [TBL] [Abstract][Full Text] [Related]
18. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute. Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286 [TBL] [Abstract][Full Text] [Related]
19. Feasibility and efficacy of combination therapy with preoperative and postoperative chemoradiation, extended pancreatectomy, and postoperative liver perfusion chemotherapy for locally advanced cancers of the pancreatic head. Ohigashi H; Ishikawa O; Eguchi H; Sasaki Y; Yamada T; Noura S; Murata K; Takachi K; Miyashiro I; Doki Y; Imaoka S; Kasugai T; Nishiyama K Ann Surg Oncol; 2005 Aug; 12(8):629-36. PubMed ID: 15968497 [TBL] [Abstract][Full Text] [Related]
20. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes. Martin RC; Scoggins CR; Egnatashvili V; Staley CA; McMasters KM; Kooby DA Arch Surg; 2009 Feb; 144(2):154-9. PubMed ID: 19221327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]